I picked up a few more shares of the STJO shell this morning under ten cents. Hard to ignore this shell/RM at that kind of legacy share valuation. The immediate post-RM share structure appears to be excellent, and it looks like there will be some interesting potential catalysts approaching.
The above paragraph from the STJO press release probably will not get as much attention as other parts of the release, but I find it quite intriguing. Cypress Technologies is the company that manufactures all of MedHab's medical devices. It will be very interesting to see if the plan is to buy part of the Cypress production facility, or if the plan is to acquire the entire company of Cypress.